Year: 2002
Type: dissertation
Abstract: Introduction nproductionn in cell lines transfected with the TSH receptor (23).It should be noted that the TBIII assay does not discriminate between TSAb and TSBAb.The large majority of these TSHH receptor antibodies is stimulatory, resulting in hyperthyroidism and goitre (24).A small percentagee blocks thyroid functions by inhibiting or even without interferingg with TSH binding (29)(30)(31)).An even smaller percentage is considered neutral and doess not affect TSH receptor activation, nor blocks TSH binding (32).Treatment of Graves' hyperthyroidismm with antithyroid drugs usually restores euthyroidism clinically and biochemicallyy (defined by normal free T 4 and T 3 levels) within 1 to 2 months (33).This is typicallyy accompanied by a decrease in autoantibody titres.Remarkably,, during adequate treatment of Graves' hyperthyroidism there is no consistentt correlation between free T 4 levels and TSH levels once normal free T 4 and T3 serumm concentrations have been restored.In clinical practice it is frequently observed that euthyroid,, treated Graves' disease patients with normal, or even low, thyroid hormone levels showw suppressed plasma TSH levels for months or even years after euthyroidism has been establishedd (33,34).The only explanation for this phenomenon provided to date has been a delayedd recovery of the thyrotrophs from a prolonged hyperthyroid state (35,36).However, experimentall evidence to support this theory has been lacking so far. ULTRA-SHORT LOOP FEEDBACK IN THE ANTERIOR PITUITARYOverr the last decade it has become clear that, in addition to central feed forward and peripherall feedback control, additional autocrine and paracrine mechanisms within the anteriorr pituitary also influence pituitary hormone secretion (37-39).This offers the possibilityy of fine regulation of hormone secretion at the pituitary level.By analogy with a modernn central heating system that measures and regulates its own heat production by a centrall thermostat (Figure 1.3), the pituitary could harbour such a central thermostat.The animall body is, after all, a machine, a device that utilises energy to produce or execute certain functions.. Monitoring the production of its own secretagogues might enable the pituitary to fine-regulatee hormone secretion more efficiently. 6forr the loss of ultra-short loop feedback.For an extensive review on the complex regulation of PRLL secretion, see Ref. (52).Prolactinn secretion is also modulated by folliculo-stellate cells.In the anterior pituitary thesee cells are the only source of interleukin-6 (IL-6) (53).This cytokine has been shown to stimulatee prolactin secretion, both in vitro and in vivo (54,55).However, folliculo-stellate cellss suppress the prolactin-secretory response to angiotensin II and TRH when they are culturedd with lactotrophs as cell aggregates.Intimate contact between folliculo-stellate cells andd lactotrophs is not required for this inhibition, since it is still observed after dispersion of thee co-aggregates into single cells ( 41).This suggests that a diffusable inhibitory factor, differentt from IL-6, is secreted by the folliculo-stellate cells and suppresses prolactin secretion..However, the identity of this putative paracrine factor is unknown.Further,, PRL-releasing peptide was long believed to be released by the hypothalamus only,, but the detection of PRL-releasing peptide as well as its receptor in the human anterior pituitaryy also suggests a paracrine or autocrine role for this peptide (56). Ultra-shortt loop regulation of GH secretionUltra-shortt loop regulation within the pituitary has also been suggested for growth hormone (GH)) secretion.Using double immunocytochemistry, Mertani and co-workers (57) showed thatt the GH receptor is expressed in the human anterior pituitary by somatotrophs, lactotrophs,, and gonadotrophs but not in the thyrotrophs or corticotrophs.In the rodent pituitary,, GH receptor and/or binding protein expression has also been demonstrated in somatotrophss as well as in other hormone producing cells (58-61).Furthermore, Asa and coworkersworkers (62) found that somatotrophs in transgenic mice expressing a GH antagonist become hyperactivee as observed by increased synthetic and secretory activity at the electronmicroscopicall level.Since this stimulatory effect on the activity of the somatotrophs was even strongerr in transgenic mice that were devoid of the GH receptor, these findings are consistent withh a direct inhibition by GH on pituitary somatotrophs.A direct negative feedback by GH onn its own secretion was also demonstrated in intact rainbow trout pituitary using an in vitro perifusionn system (63).Pituitaries exposed to increasing doses of ovine GH, before being returnedd to a GH-free perifusion, indeed showed a dose-dependent inhibition of GH secretion.However,, Veldhuis and co-workers (64) showed that, in addition, GH feeds back on the centrall nervous system regulatory centres via specific brain GH receptors.TSH activates 8
Author: Leon J. S. Brokken
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1943558557
